To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Clinical trial NCT05101135 · UNKNOWN
Trial details
- NCT number
- NCT05101135
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2022-10-31
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.